MANAGING THE RISK OF THROMBOSIS IN THE PERIOPERATIVE PERIOD IN PATIENTS UNDERGOING ORTHOPEDIC AND TRAUMA SURGERY WITH LOW-MOLECULAR-WEIGHT HEPARIN - ENOXAPARIN

Patients undergoing arthroplastic surgery of the lower limbs and those with multiple injuries have a high risk of thromboembolism. Enoxapari n is a highly effective antithrombotic drug that is well tolerated and without the need for monitoring. Numerous controlled trials in these patient groups have demonstrated enoxaparin to be at least as effectiv e as heparin in reducing the occurrence of deep vein thrombosis while showing a tendency towards lower risk of bleeding complications; there fore, enoxaparin is recommended as thromboprophylaxis in patients unde rgoing major hip or knee surgery or suffering from multiple trauma.